| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SS18L2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | UTF1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | PPP1CC | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | TLR10 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | SNAP25 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | KCNE3 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | ARL8A | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | PFDN4 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | ARRDC2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | ZNF136 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |
